The studies amplify what Joseph Balboni experienced as soon as he started wearing scleral lenses BOS-P: there is nothing clear vision without pain to change your outlook on life.In the December issue of the Journal of Ophthalmology, researchers at Brandeis University, has published a document assessing the economic benefits of BOS-P scleral a high precision lens used to treat severe corneal disease or ocular surface. A supplementary document on the clinical benefits have been published online and will appear in the magazine in January.
The studies were conducted by a team of researchers from Heller School of Brandeis University, which included William B. Stason, MD, principal investigator, Donald Shepard, Ph.D.
The research team said: ‘We were pleasantly surprised by the results of our studies, because the scleral lens is an expensive device, but it turned out to be both profitable and offers a significant improvement in quality of life.’
Giuseppe Balboni loves sports. A tennis player and avid golfer and baseball fan, the insurance agent of 46 years it has become increasingly frustrated by the time his gray eyes because of keratoconus, a degenerative eye disease. Capable of returning the tennis ball or see the lawn of the Red Sox game, he faced the prospect of a corneal transplant to restore vision and eye comfort.
The study did not seem depressed mood or depression during pregnancy because the larger research project did not collect these data. He hopes to replicate and extend the results by analyzing data from another study to look for depression prior to pregnancy and child poverty to see if these two factors partly explain the difference in black and white in a premature birth. This study will also examine the role play of the antidepressant drug of premature births.
Then three years ago, Balboni discovered an alternative treatment. He received a scleral gas permeable lenses , known as the ocular surface prosthesis Boston of the Boston Foundation for Sight in Needham, MA. ‘The scleral lens changed my life,’ said Balboni.
‘ Balboni’s insurance company paid for the lion’s share of the approximately $ 8000 for the treatment and adjustment of the lens, even if the insurance coverage of destination is not routine.